Extensive SUMO Modification of Repressive Chromatin Factors Distinguishes Pluripotent from Somatic Cells
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Extensive SUMO Modification of Repressive Chromatin Factors Distinguishes Pluripotent from Somatic Cells. / Theurillat, Ilan; Hendriks, Ivo A.; Cossec, Jack-Christophe; Andrieux, Alexandra; Nielsen, Michael L.; Dejean, Anne.
In: Cell Reports, Vol. 32, No. 11, 108146, 2020.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Extensive SUMO Modification of Repressive Chromatin Factors Distinguishes Pluripotent from Somatic Cells
AU - Theurillat, Ilan
AU - Hendriks, Ivo A.
AU - Cossec, Jack-Christophe
AU - Andrieux, Alexandra
AU - Nielsen, Michael L.
AU - Dejean, Anne
PY - 2020
Y1 - 2020
N2 - Post-translational modification by SUMO is a key regulator of cell identity. In mouse embryonic fibroblasts (MEFs), SUMO impedes reprogramming to pluripotency, while in embryonic stem cells (ESCs), it represses the emergence of totipotent-like cells, suggesting that SUMO targets distinct substrates to preserve somatic and pluripotent states. Using MS-based proteomics, we show that the composition of endogenous SUMOylomes differs dramatically between MEFs and ESCs. In MEFs, SUMO2/3 targets proteins associated with canonical SUMO functions, such as splicing, and transcriptional regulators driving somatic enhancer selection. In contrast, in ESCs, SUMO2/3 primarily modifies highly interconnected repressive chromatin complexes, thereby preventing chromatin opening and transitioning to totipotent-like states. We also characterize several SUMO-modified pluripotency factors and show that SUMOylation of Dppa2 and Dppa4 impedes the conversion to 2-cell-embryo-like states. Altogether, we propose that rewiring the repertoire of SUMO target networks is a major driver of cell fate decision during embryonic development.
AB - Post-translational modification by SUMO is a key regulator of cell identity. In mouse embryonic fibroblasts (MEFs), SUMO impedes reprogramming to pluripotency, while in embryonic stem cells (ESCs), it represses the emergence of totipotent-like cells, suggesting that SUMO targets distinct substrates to preserve somatic and pluripotent states. Using MS-based proteomics, we show that the composition of endogenous SUMOylomes differs dramatically between MEFs and ESCs. In MEFs, SUMO2/3 targets proteins associated with canonical SUMO functions, such as splicing, and transcriptional regulators driving somatic enhancer selection. In contrast, in ESCs, SUMO2/3 primarily modifies highly interconnected repressive chromatin complexes, thereby preventing chromatin opening and transitioning to totipotent-like states. We also characterize several SUMO-modified pluripotency factors and show that SUMOylation of Dppa2 and Dppa4 impedes the conversion to 2-cell-embryo-like states. Altogether, we propose that rewiring the repertoire of SUMO target networks is a major driver of cell fate decision during embryonic development.
KW - TRANSCRIPTION FACTORS
KW - SUMOYLATION
KW - IDENTIFICATION
KW - INSIGHTS
KW - PATHWAY
KW - COMPLEX
KW - BINDING
U2 - 10.1016/j.celrep.2020.108146
DO - 10.1016/j.celrep.2020.108146
M3 - Journal article
C2 - 32937131
VL - 32
JO - Cell Reports
JF - Cell Reports
SN - 2211-1247
IS - 11
M1 - 108146
ER -
ID: 250123296